| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/30/2011 | CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof |
| 03/30/2011 | CN101993474A Glaucocalyxin A derivatives with cyclic octapeptide structure as well as preparation method and application of glaucocalyxin A derivatives |
| 03/30/2011 | CN101993473A Polypeptide glaucocalyxin A derivatives as well as preparation method and application thereof |
| 03/30/2011 | CN101993464A Preparation method of capecitabine |
| 03/30/2011 | CN101993446A Novel benzanthracene cyclic compounds and preparation method and use thereof |
| 03/30/2011 | CN101993432A Carbazoles chalcone derivatives based on carbazole and preparation method thereof |
| 03/30/2011 | CN101993416A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound |
| 03/30/2011 | CN101993415A Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
| 03/30/2011 | CN101993388A Dimerization cassaine alkaloids as well as preparation method, pharmaceutical compositions and applications of dimerization cassaine alkaloids |
| 03/30/2011 | CN101993373A Chlorinated glaucocalyxin A derivative and preparation method and application thereof |
| 03/30/2011 | CN101993370A Glaucocalyxin A acid ester derivative as well as preparation method and application of Glaucocalyxin A acid ester derivative |
| 03/30/2011 | CN101993359A Fatty acid derivative of glaucocalyxin A, as well as preparation method and applications thereof |
| 03/30/2011 | CN101991862A Cyclodextrin-polyethyleneimine-mediated supramolecular delivery system and preparation method |
| 03/30/2011 | CN101991861A Preparation method of gamma-Fe2O3/polyaniline-L-dopa |
| 03/30/2011 | CN101991851A Ultrasound microbubble agent for treating tumors by low-intensity focused ultrasound and preparation method thereof |
| 03/30/2011 | CN101991843A Multiple antigen peptide (MAP) vaccine and application thereof |
| 03/30/2011 | CN101991841A Medical composition for treating cancer and preparation method thereof |
| 03/30/2011 | CN101991840A Method for preparing prostate cancer-resisting mussel enzymolytic extract and application thereof |
| 03/30/2011 | CN101991807A Chinese herbal compound for treating liver cancer |
| 03/30/2011 | CN101991789A Preparation with functions of clearing away heat and toxic material and diminishing swelling and preparation method thereof |
| 03/30/2011 | CN101991775A Cancer-eliminating medicinal liquor and preparation method thereof |
| 03/30/2011 | CN101991770A Medicament for treating malignant tumors |
| 03/30/2011 | CN101991751A Medicament for treating tumors |
| 03/30/2011 | CN101991732A Traditional Chinese medicine composite for treating liver cancer |
| 03/30/2011 | CN101991665A Composition for treating myocardial diseases, femoral head necrosis and tumor and preparation process thereof |
| 03/30/2011 | CN101991637A Medicament for inducing apoptosis and application thereof |
| 03/30/2011 | CN101991636A Detection method of Aidi injection preparation |
| 03/30/2011 | CN101991629A Glaucescent fissistigma root saponin composition and preparation method thereof |
| 03/30/2011 | CN101991619A Pomegranate controlled-release pellets and preparation method thereof |
| 03/30/2011 | CN101991615A Method for producing ganoderma spore by breaking wall |
| 03/30/2011 | CN101991612A Preparation method of haematococcus pluvialis extracts |
| 03/30/2011 | CN101991609A Efficient three-in-one royal jelly soft capsule |
| 03/30/2011 | CN101991608A Fly maggot extractive as well as preparation method and application thereof |
| 03/30/2011 | CN101991606A Preparation method of solid water-soluble lead-removed propolis |
| 03/30/2011 | CN101991601A Method for preparing uroacitide composition |
| 03/30/2011 | CN101991600A Application of lithium preparation in preparation of anti-osteosarcoma medicament |
| 03/30/2011 | CN101991599A Medicine for dissolving and eliminating diseased tissue and pathogen |
| 03/30/2011 | CN101991593A Application of quercetin in medicament preparation |
| 03/30/2011 | CN101991590A Stilbene glucoside medical composite and preparation method thereof |
| 03/30/2011 | CN101991581A Application of 3beta, 6beta, 7alpha-trihydroxy-(24R)ergosta-8(14),22-diene in preparation of anti-cancer drugs |
| 03/30/2011 | CN101991579A Use of ursolic acid as colon tumor resistant medicament |
| 03/30/2011 | CN101991575A Application of evodiamine in preparing medicine for inhibiting aryl hydrocarbon receptor |
| 03/30/2011 | CN101991571A Application of curcumin plus mitomycin C in preparing medicine used for treating breast cancer |
| 03/30/2011 | CN101991565A Application of salvianolic acid A in preparing medicament for inducing apoptosis of tumor cells and/or inhibiting propagation of tumor cells |
| 03/30/2011 | CN101991560A Method for preparing WR-2721 enteric-coated microcapsules |
| 03/30/2011 | CN101991556A Letrazole film coated tablet and preparation method thereof |
| 03/30/2011 | CN101991553A Exemestane tablet and preparation method thereof |
| 03/30/2011 | CN101991550A Norcantharidin tablet and preparation method thereof |
| 03/30/2011 | CN101991538A TPGS-containing liposome composition and application thereof |
| 03/30/2011 | CN101991537A Compound fluorouracil liposome oral liquid and preparation method thereof |
| 03/30/2011 | CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 03/30/2011 | CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof |
| 03/30/2011 | CN101991532A Self-microemulsion composition, microemulsion and preparation methods thereof |
| 03/30/2011 | CN101991516A Health care cosmetic prepared from raw materials taxus chinensis essential oil and taxus chinensis extracts |
| 03/30/2011 | CN101991099A Ginseng can |
| 03/30/2011 | CN101612383B Medicine for treating stomach cancer and esophagus cancer and preparation method thereof |
| 03/30/2011 | CN101606947B Gemcitabine hydrochloride composition and preparation method thereof |
| 03/30/2011 | CN101491518B Combination for treating tumor |
| 03/30/2011 | CN101485637B Colchicine framework controlled release tablets or capsules |
| 03/30/2011 | CN101475583B Dibutyl tin dichloride schiff alkali coordination compound, as well as preparation method and application thereof |
| 03/30/2011 | CN101440118B Saponin compound extracted from Momordica grosvenori root, preparation and use thereof |
| 03/30/2011 | CN101433546B Capecitabine sustained and controlled release oral formulation and preparation method thereof |
| 03/30/2011 | CN101416950B Preparation method of cmellia sponin controlled release tablets |
| 03/30/2011 | CN101397241B Ent-abieta diterpenoid largeleaf rabdosia leaf I and J, preparation method and use thereof |
| 03/30/2011 | CN101375839B Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/30/2011 | CN101317816B Docetaxel long-circulation formulation |
| 03/30/2011 | CN101185643B Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 03/30/2011 | CN101181339B Detection method of aidi injection preparations |
| 03/30/2011 | CN101045163B High molecular anticarcinogenic prodrug, its preparing method and use |
| 03/30/2011 | CN101041016B Medicine for curing pituitary adenoma and its preparation method |
| 03/29/2011 | US7915408 Triazolotriazines as kinase inhibitors |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915294 Method of treating colorectal carcinoma |
| 03/29/2011 | US7915287 Substituted heterocycles and methods of use |
| 03/29/2011 | US7915281 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915268 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 03/29/2011 | US7915266 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915237 Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7915040 Defensin-antigen fusion proteins |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7914787 Provide inter alia a bi-specific antibody or antibody fragment having one arm that specifically binds a targeted tissue and one other arm that specifically binds a targetable conjugate that can be modified for use in a wide variety of diagnostic and therapeutic applications |
| 03/29/2011 | CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2472114C 2-o-(.beta.-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositons comprising it |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2447040C Assays, methods and means |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2435146C Formulation of boronic acid compounds |
| 03/29/2011 | CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder |